Dermatology Nursing - Herbal remedies for psoriasis: what are our patients taking?
October 1, 2007 -- Herbal and supplement aisles abound in supermarkets and local health food stores nationwide, providing evidence of the booming market for...
Independent, The (London) - Tacing: HYPERION'S TV TIPS
August 2, 2000 -- GOODWOOD 2.15: Last year's Cesarewitch flop Silent Warning returned to action with a cracking effort against Ski Run at Ascot last Friday. He can...
Ear, Nose & Throat Journal - Tongue erosions and diet cola
April 1, 2007 -- Abstract We report the case of a 38-year-old woman who presented with a 10-year history of painful ulcerations on her tongue. She reported that she...
Dermatology Nursing - Allergic contact dermatitis: early recognition and diagnosis of important allergens
October 1, 2006 -- Allergic contact dermatitis (ACD) is a commonly seen ailment of patients visiting general medical practices and dermatology clinics. ACD was the...
Chemical Market Reporter - TACE INHIBITOR.(Brief Article)
April 9, 2001 -- DuPont Pharmaceuticals has commenced Phase II trials in North America and Europe in patients with rheumatoid arthritis for its oral Tumor Necrosis...
Market Wire - Chemokine Therapeutics Announces Liver Cancer Data Presented at the AACR Meeting on Its Lead Compound, CTCE-9908
April 30, 2008 -- Chemokine Therapeutics Corp. ("Chemokine Therapeutics" or the "Company") (TSX: CTI) (OTCBB: CHKT), a biotechnology company developing chemokine-based...
HealthDay - Two Liver Cancer Treatments Better Than One
April 8, 2008 -- By combining a special type of chemotherapy (TACE) with another treatment called radiofrequency ablation (RFA), Chinese researchers boosted the...
AFP - Combo therapy extends life for liver cancer patients: study
April 8, 2008 -- WASHINGTON (AFP) — Patients with advanced liver cancer may live longer if they receive a combination of a certain kind of chemotherapy and...
Market Wire - Chemokine Therapeutics Receives Approval From Health Canada to Commence Phase II Study in Liver Cancer
March 5, 2008 -- Chemokine Therapeutics Corp. (the "Company") (TSX: CTI)(OTCBB: CHKT), a biotechnology company developing chemokine-based therapies to treat cancer,...
Market Wire - Chemokine Therapeutics Receives Approval From FDA to Commence Phase II Study
January 8, 2008 -- Chemokine Therapeutics Corp. (the "Company") (TSX: CTI)(OTCBB: CHKT), a biotechnology company developing chemokine-based therapies to treat cancer,...
